title: Candida albicans biofilm development on medically-relevant foreign bodies in a mouse subcutaneous model followed by bioluminescence imaging.
abstract: Candida albicans biofilm development on biotic and/or abiotic surfaces represents a specific threat for hospitalized patients. So far, C. albicans biofilms have been studied predominantly in vitro but there is a crucial need for better understanding of this dynamic process under in vivo conditions. We developed an in vivo subcutaneous rat model to study C. albicans biofilm formation. In our model, multiple (up to 9) Candida-infected devices are implanted to the back part of the animal. This gives us a major advantage over the central venous catheter model system as it allows us to study several independent biofilms in one animal. Recently, we adapted this model to study C. albicans biofilm development in BALB/c mice. In this model, mature C. albicans biofilms develop within 48 hr and demonstrate the typical three-dimensional biofilm architecture. The quantification of fungal biofilm is traditionally analyzed post mortem and requires host sacrifice. Because this requires the use of many animals to perform kinetic studies, we applied non-invasive bioluminescence imaging (BLI) to longitudinally follow up in vivo mature C. albicans biofilms developing in our subcutaneous model. C. albicans cells were engineered to express the Gaussia princeps luciferase gene (gLuc) attached to the cell wall. The bioluminescence signal is produced by the luciferase that converts the added substrate coelenterazine into light that can be measured. The BLI signal resembled cell counts obtained from explanted catheters. Non-invasive imaging for quantifying in vivo biofilm formation provides immediate applications for the screening and validation of antifungal drugs under in vivo conditions, as well as for studies based on host-pathogen interactions, hereby contributing to a better understanding of the pathogenesis of catheter-associated infections.
authors: Department of Molecular Microbiology, Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, VIB, KU Leuven.
authors: Soňa
authors: S
authors: Kucharíková
authors: Biomedical MRI Unit/ MoSAIC, Department of Imaging & Pathology, KU Leuven.
authors: Greetje
authors: G
authors: Vande Velde
authors: Biomedical MRI Unit/ MoSAIC, Department of Imaging & Pathology, KU Leuven.
authors: Uwe
authors: U
authors: Himmelreich
authors: Department of Molecular Microbiology, Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, VIB, KU Leuven; Patrick.VanDijck@mmbio.vib-kuleuven.be.
authors: Patrick
authors: P
authors: Van Dijck
mesh_terms: D000818:Animals; D018441:Biofilms / Q000254:growth & development*; D002176:Candida albicans / Q000502:physiology*; D055499:Catheter-Related Infections / Q000382:microbiology; D057785:Catheters / Q000382:microbiology*; D004195:Disease Models, Animal; D005260:Female; D005547:Foreign Bodies / Q000382:microbiology; D008156:Luciferases / Q000032:analysis; D008163:Luminescent Measurements / Q000379:methods*; D051379:Mice; D008807:Mice, Inbred BALB C; D011140:Polyurethanes
chemical_list: D011140:Polyurethanes; D008156:Luciferases
references: Ther Clin Risk Manag. 2014 Feb 13;10:95-105
references: 24611015
references: Int J Microbiol. 2012;2012:845352
references: 22164167
references: Antimicrob Agents Chemother. 2013 May;57(5):2365-8
references: 23403433
references: Microb Pathog. 2006 Feb;40(2):82-90
references: 16426810
references: Curr Genet. 2013 Nov;59(4):251-64
references: 23974350
references: Infect Immun. 2009 Nov;77(11):4847-58
references: 19687206
references: Methods Mol Biol. 2014;1098:153-67
references: 24166376
references: Microbiology. 2010 Mar;156(Pt 3):909-19
references: 19959578
references: Curr Gene Ther. 2012 Feb 1;12(1):12-9
references: 22263920
references: Microbiology. 2010 Dec;156(Pt 12):3635-44
references: 20705667
references: Cell Microbiol. 2014 Jan;16(1):115-30
references: 23962311
references: Infect Immun. 2010 Sep;78(9):3650-9
references: 20605982
references: Future Microbiol. 2013 Oct;8(10):1325-37
references: 24059922
references: Virulence. 2013 Apr 1;4(3):250-4
references: 23334179
references: J Antimicrob Chemother. 2009 Sep;64(3):567-70
references: 19584104
references: Antimicrob Agents Chemother. 2004 May;48(5):1727-32
references: 15105127
references: J Antimicrob Chemother. 1999 Nov;44(5):669-74
references: 10552984
references: Curr Biol. 2005 Jun 21;15(12):1150-5
references: 15964282
references: J Med Microbiol. 2011 Oct;60(Pt 10):1523-9
references: 21596904
references: PLoS One. 2009 Nov 24;4(11):e7967
references: 19956771
references: Antimicrob Agents Chemother. 2010 Oct;54(10):4474-5
references: 20660685
references: Infect Immun. 2004 Oct;72(10):6023-31
references: 15385506
references: J Infect Dis. 2012 Dec 1;206(11):1790-7
references: 22984120
references: Antimicrob Agents Chemother. 2002 Jun;46(6):1773-80
references: 12019089
references: Antimicrob Agents Chemother. 2013 May;57(5):2369-71
references: 23422915